These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9840026)

  • 1. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin.
    de Haan J; van Oeveren W
    Thromb Res; 1998 Nov; 92(4):171-9. PubMed ID: 9840026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM; Kalnoski MH; Frederick M; Chandler WL
    Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery.
    Huang H; Ding W; Su Z; Zhang W
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):11-8. PubMed ID: 7686594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
    Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
    Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets.
    Orchard MA; Goodchild CS; Prentice CR; Davies JA; Benoit SE; Creighton-Kemsford LJ; Gaffney PJ; Michelson AD
    Br J Haematol; 1993 Nov; 85(3):533-41. PubMed ID: 7510990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation.
    Stricker RB; Wong D; Shiu DT; Reyes PT; Shuman MA
    Blood; 1986 Jul; 68(1):275-80. PubMed ID: 2941084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased urokinase and consumption of α
    Longstaff C; Locke M
    J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
    Walker JB; Bajzar L
    J Thromb Haemost; 2007 Jun; 5(6):1257-64. PubMed ID: 17389009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass.
    Ray MJ; Marsh NA; Hawson GA
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):679-85. PubMed ID: 7865673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostasis in patients undergoing extracorporeal circulation: the effect of aprotinin (Trasylol).
    Lu H; Soria C; Commin PL; Soria J; Piwnica A; Schumann F; Regnier O; Legrand Y; Caen JP
    Thromb Haemost; 1991 Dec; 66(6):633-7. PubMed ID: 1724577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of staphylokinase on platelet aggregation.
    Suehiro A; Oura Y; Ueda M; Kakishita E
    Thromb Haemost; 1993 Nov; 70(5):834-7. PubMed ID: 7510426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss.
    Mastroroberto P; Chello M; Zofrea S; Marchese AR
    Eur J Cardiothorac Surg; 1995; 9(3):143-5. PubMed ID: 7540397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible translocation of glycoprotein Ib in plasmin-treated platelets: consequences for platelet function.
    Lu H; Soria C; Soria J; De Romeuf C; Perrot JY; Tenza D; Garcia I; Caen JP; Cramer EM
    Eur J Clin Invest; 1993 Dec; 23(12):785-93. PubMed ID: 7511534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation by alpha 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma.
    Silence K; Collen D; Lijnen HR
    Blood; 1993 Aug; 82(4):1175-83. PubMed ID: 7688990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis.
    Gouin I; Lecompte T; Morel MC; Lebrazi J; Modderman PW; Kaplan C; Samama MM
    Circulation; 1992 Mar; 85(3):935-41. PubMed ID: 1531623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of plasmin-induced platelet aggregation.
    Watabe A; Ohta M; Matsuyama N; Mizuno K; el Borai N; Tanimoto T; Kawanishi T; Hayakawa T
    Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):341-52. PubMed ID: 9261893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.